Isoform-specific alterations in cardiac and erythrocyte Na+,K+-ATPase activity induced by norepinephrine

Journal of Cardiac Failure

Volumn 4, Issue 4, 1998, Pages 333-341

  Baba, Akiyasu ^a   Yoshikawa, Tsutomu ^a   Nakamura, Iwao ^a   Iwata, Michikado ^a   Wainai, Yumiko ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Catecholamine; Erythrocyte; Myocardium; Na+,K+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CATECHOLAMINE; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ERYTHROCYTE MEMBRANE; HEART LEFT VENTRICLE; HEART MUSCLE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032421736     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(98)90239-1     Document Type: Article

References (43)

1. Craig WS, Kyte J: Stoichiometry and molecular weight of the minimum asymmetric unit of canine renal sodium and potassium ion-activated adenosine triphosphatase. J Biol Chem 1980;255:6262-9
2. +) ATPase deduced from a complementary DNA. Nature 1985;316:691-5
3. +-ATPase alpha-subunit from rat brain. Biochemistry 1986;25:8125-32
4. +-ATPase. Biochem Biophys Res Commun 1987; 145:52-8
5. +-pump concentration in suspected idiopathic dilated cardiomyopathy. Am J Cardiol 1988;61:1312-5
6. +-pump in skeletal and heart muscle in congestive heart failure. Int J Cardiol 1990;26:185-90
7. +-ATPase activity and ouabain binding sites in heart failure: prevention by nadolol. Am J Physiol 1993;265:H2086-93
8. Priori SG, Corr PB: Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am J Physiol 1990;258:H1776-805
9. Ming Z, Aronson R, Nordin C: Mechanism of current-induced early afterdepolarizations in guinea pig ventricular myocytes. Am J Physiol 1994;267:H1419-28
10. Swann AC: Stimulation of brain Na,K-ATPase by norepinephrine in vivo: prevention by receptor antagonists and enhancement by repeated stimulation. Brain Res 1983;260: 338-41
11. +)-adenosine triphosphatase regulation by the sympathetic nervous system: effects of noradrenergic stimulation and lesions in vivo. J Pharmacol Exp Ther 1984;228:304-11
12. Wanless RB, Noble MI, Drake-Holland AJ: Effects of noradrenaline on the sodium pump of guinea pig ventricle. Adv Myocardiol 1985;6:97-104
13. +-pump in skeletal muscle. J Auton Pharmacol 1990;10:227-31
14. Taylor RB, Reid R, Kendle KE, Geddes C, Curle PF: Assay procedures for the determination of biogenic amines and their metabolites in rat hypothalamus using ion-pairing reversed-phase high-performance liquid chromatography. J Chromatogr 1983;277:101-14
15. Yoshikawa T, Handa S, Suzuki M, Nagami K: Abnormalities in sympathoneuronal regulation are localized to failing myocardium in rabbit heart. J Am Coll Cardiol 1994; 24:210-5
16. Anzai T, Yoshikawa T, Baba A, Nishimura H, Shiraki H, Nagami K, Suzuki M, Wainai Y, Ogawa S: Myocardial sympathetic denervation prevents chamber-specific alteration of β-adrenergic transmembrane signaling in heart failure. J Am Coll Cardiol 1996;28:1314-22
17. Zak B, Cohen J: Automatic analysis of tissue culture proteins with stable Folin reagents. Clin Chem Acta 1961; 6:665-70
18. +-ATPase in red blood cell membranes. J Trace Elem Electrolytes Health Dis 1989;3: 151-9
19. Jones LR, Besch JR Jr: Isolation of canine sarcolemmal vesicles. Methods Pharmacol 1984;5:1-12
20. Harris WD, Popat P: Determination of the phosphorus content of lipids. J Am Oil Chem Soc 1954;31:124-7
21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5
22. Panagia V, Singh JN, Anand-Srivastava MB, Pierce GN, Jasmin G, Dhalla NS: Sarcolemmal alterations during the development of genetically determined cardiomyopathy. Cardiovasc Res 1984;18:567-72
23. +-ATPase activity in cardiomyopathic hamsters as estimated from K-dependent 3-O-MFPase activity in crude homogenates. J Mol Cell Cardiol 1987;19:589-94
24. +-ATPase α-subunit in congestive heart failure: role of norepinephrine. Circulation 1994;89:313-20
25. +-ATPase: I. Role of cyclic AMP and phospholipase A2. J Clin Invest 1992;89:1496-500
26. +)-ATPase activity by cyclic AMP. Biochim Biophys Acta 1982;688:475-85
27. +-ATPase after exposure to exogenous phospholipase A2. Am J Physiol 1987;252:H32-9
28. Mak IT, Weglicki WB: Protection by β-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 1988;63:262-6
29. Pugh SE, White NJ, Aronson JK, Grahame-Smith D, Bloomfield JG: Clinical, haemodynamic and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment. Br Heart J 1989;61:529-39
30. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV, Fowler MB, Ginsburg R: β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 1992;89:803-15
31. Sethi R, Dhalla KS, Beamish RE, Dhalla NS: Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure. Am J Physiol 1997;272: H884-93
32. Dhir R, Nishioka Y, Blostein R: Na,K-ATPase isoform expression in sheep red blood cell precursors. Biochim Biophys Acta 1990;1016:141-6
33. +-ATPase alpha subunit in the rabbits kidney? J Biol Chem 1993;268:11512-5
34. +-ATPase with different pharmacological and immunological properties in the rat kidney. Pflugers Arch 1995;430:205-12
35. +-ATPase in human heart. Biochim Biophys Acta 1993;1149: 189-94
36. +-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovasc Res 1993;27:2229-37
37. Barbey O, Gerbi A, Paganelli F, Robert K, Levy S, Maixent JM: Canine cardiac digitalis receptors are preserved in congestive heart failure induced by rapid ventricular pacing. J Recept Res 1997;17:447-58
38. +-ATPase α-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuli. J Mol Cell Cardiol 1997;29:3157-67
39. +-ATPase isoforms in myocardium: isoform change in deoxycorticosterone acetate-salt hypertension. Circ Res 1994;74:669-78
40. +-ATPase alpha1-but not alpha3-isoform. Am J Physiol 1994;266:H1221-7
41. +-ATPase isoform gene expression in normal and hypertrophied dog heart. Basic Res Cardiol 1996;91:256-66
42. +-stimulated ATPase in brain: separation and difference in affinity for strophanthidin. J Biol Chem 1979;254:6060-7
43. +-ATPase in heart failure. Eur J Pharmacol 1996;309:235-41